Equities

Amedisys Inc

Amedisys Inc

Actions
  • Price (CHF)--
  • Today's Change--
  • Shares traded0.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
OPERATIONS
Net income(11)118210
Depreciation/depletion242531
Non-Cash items1677234
Cash taxes paid, supplemental292434
Cash interest paid, supplemental30285.29
Changes in working capital(63)(105)(131)
Total cash from operations137133189
INVESTING
Capital expenditures(13)(7.22)(6.72)
Other investing and cash flow items, total48(87)(275)
Total cash from investing35(94)(282)
FINANCING
Financing cash flow items(14)(5.94)(81)
Total cash dividends paid------
Issuance (retirement) of stock, net2.70(11)(94)
Issuance (retirement) of debt, net(76)(13)230
Total cash from financing(88)(30)55
NET CHANGE IN CASH
Foreign exchange effects------
Net change in cash858.36(38)
Net cash-begin balance/reserved for future use544683
Net cash-end balance/reserved for future use1395446
SUPPLEMENTAL INCOME
Depreciation, supplemental242531
Cash interest paid, supplemental30285.29
Cash taxes paid, supplemental292434
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.